Table 1. Demographic information and baseline clinical characteristics of study population (n = 136).
ABSST: Actionable Bladder Symptom Screening Tool [19]; EDSS: Expanded Disability Status Scale [17]; MFIS: Modified Fatigue Impact Scale [26]; RFIS: Revised Faecal Incontinence Scale [22]; SD: Standard Deviation.
| Age | |
| Mean (SD) | 56.1 (12.3) |
| Range | 25–81 |
| Gender | |
| Male | 46/136 (33.8%) |
| Female | 90/136 (66.2%) |
| Type of MS | |
| Relapse Remitting | 44/136 (32.4%) |
| Secondary Progressive | 58/136 (42.6%) |
| Primary Progressive | 27/136 (19.9%) |
| Unknown | 7/136 (5.1%) |
| No. of years since diagnosis | |
| Mean (SD) | 18.2 (10.8) |
| Range | 1–43 |
| Age of MS onset | |
| Mean (SD) | 38.0 (13.0) |
| Range | 9–69 |
| EDSS scores | |
| 0–4.5 (fully ambulatory) | 37/136 (27.2%) |
| 5–7.5 (ambulatory with aid) | 84/136 (61.8%) |
| 8–10 (non-ambulatory) | 14/136 (10.3%) |
| Unknown | 1/136 (0.7%) |
| ABSST scores | |
| Mean (SD) | 8.52 (4.66) |
| Range | 0–21 |
| RFIS scores | |
| Mean (SD) | 2.85 (3.97) |
| Range | 0–18 |
| MFIS scores | |
| Mean (SD) | 39.7 (19.1) |
| Range | 0–77 |